ZTS FY 2023 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$8.5B+5.7% YoY

Gross Profit

$5.8B68.3% margin

Operating Income

$3.1B35.9% margin

Net Income

$2.3B27.4% margin

EPS (Diluted)

$5.07

Cash Flow

Operating Cash Flow

$2.4B

Free Cash Flow

$1.6B

Stock-Based Comp.

$60M

Balance Sheet

Total Assets

$14.3B

Total Liabilities

$9.3B

Stockholders' Equity

$5.0B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.5B	$8.1B	+5.7%
Gross Profit	$5.8B	$5.5B	+6.5%
Operating Income	$3.1B	$2.9B	+4.8%
Net Income	$2.3B	$2.1B	+10.9%